Lolium perenne peptides for treatment of grass pollen allergy: a randomized, double-blind, placebo-controlled clinical trial
File(s)Unmarked Shamji et al. Figure 1 .pptx (8.57 MB) Unmarked Figure E1 JACI-D-16-01620R2.pptx (1.99 MB)
Accepted version
Accepted version
Author(s)
Type
Journal Article
Date Issued
2018-10-10
Date Acceptance
2017-10-01
Citation
Journal of Allergy and Clinical Immunology, 2018, 141 (1), pp.448-+
ISSN
0091-6749
Publisher
Elsevier
Start Page
448
End Page
+
Journal / Book Title
Journal of Allergy and Clinical Immunology
Volume
141
Issue
1
Copyright Statement
© 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY-NCND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000419312200061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Allergy
Immunology
IMMUNOTHERAPY
SET
Publication Status
Published
Date Publish Online
2017-10-10